Hongkou Capital

Hongkou Capital is a private equity firm established in 2020 and located in New York, New York. The firm specializes in investment strategies that include buyouts and growth capital. Hongkou Capital focuses its investments on sectors such as business-to-consumer, electronics, and cleantech. As a Registered Investment Adviser, the firm is committed to managing investments in a way that aligns with regulatory standards and client interests.

Nikhil Nag

Investor

Peter Zhou

Co-Founder and Portfolio Manager

2 past transactions

Day Zero Diagnostics

Venture Round in 2022
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.

Amionx

Series B in 2021
Amionx is a leader in safe battery technology. Our Safe Core technology acts like a circuit breaker to prevent lithium-ion batteries from being the source of a fire or explosion. Our technology is applicable in all battery chemistries including solid state. Safe core protects against overcharge, internal short and external heat.it is focused on safety from the core of the battery outward.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.